Pharmaceutical Executive March 12, 2025
The prospective study reportedly showed an improvement of over 10%.
Lunit announced the results of a prospective study that looked into the usage of AI in mammography screening.1 According to the results, the powerful technology improves the detection rates for breast cancer without increasing recall rates. In a press release, Lunit states that AI improved the detection rates by 13.8%.
The study’s lead and corresponding author Professor Chang explained, “This prospective study offers compelling real-world evidence that AI can improve early cancer detection while maintaining effectiveness and reducing unnecessary patient anxiety caused by false positives in a single-reading setting.”
Lunit is an AI company that develops solutions for cancer diagnostics and therapeutics.
In the same press release, Lunit’s CEO Brandon...
Today's Sponsors
Today's Sponsor